Fundraising FoxCivilization Ventures Management, Llc — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Needham, US
Eric Schraufnagel(Founder)inAndrea Valente(Executive Officer, Director, Promoter)
BoardSteve Lindseth(Director)Bob Conway(Director)
Co-investorsHilltop Venture PartnersJoyance PartnersNelstone VenturesSocial StartsStout Street CapitalBoulder Ventures+2 more
Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.
BiotechHealthtechMedical Devices
Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Founder)inNicolo Maganzini(Founder)Tom Soh(Founder)
Co-investorsArtis VenturesFifty YearsHAWKTAILPage One VenturesPear VCFour Cities+1 more
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
BoardVishal Gulati(Director)Joel Schoppig(Director)
Co-investorsAmino CollectiveIn-Q-TelKAYARecode VenturesTech HorizonsTraun Ventures+13 more
Wyndly provides personalized allergy treatment through board-certified doctors, delivering clinical immunotherapy and testing directly to patients' homes without requiring office visits.
Digital HealthHealthtechWellness & FitnessNew York City, US
Aakash Shah(Founder/CEO)inManan Shah(Founder)inRecruiter Wyndly(Recruiter)Sophia Carvajal(Recruiting)Sophia Reyes(Executive Assistant)
Co-investorsImmeasurableY CombinatorBeagle VenturesGoodwater CapitalSide Door VenturesUnderdog Labs
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.